Theravance Biopharma (TBPH) Stock Price & Financial Analysis
Theravance Biopharma Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Theravance Biopharma
What is the current stock price for TBPH?
As of the latest trading session, TBPH stock trades at $16.58. The 52-week range is $10.44–$21.03, with a day range of $16.48–$16.85.
What is the P/E ratio for TBPH?
Theravance Biopharma's trailing P/E ratio is 7.4, meaning investors pay $7.4 for every $1 of annual earnings. Theravance Biopharma operates in the Healthcare sector.
Does TBPH pay dividends?
Theravance Biopharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for TBPH?
Based on 4 analysts, the consensus for TBPH is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of TBPH?
Theravance Biopharma's market capitalization is $850.2M, classifying it as a small-cap company. Theravance Biopharma operates in the Healthcare sector within the Biotechnology industry.